Achieve Life Sciences Inc (NAS:ACHV)
$ 5.305 0.095 (1.82%) Market Cap: 180.98 Mil Enterprise Value: 130.06 Mil PE Ratio: 0 PB Ratio: 3.66 GF Score: 37/100

Achieve Life Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript

Feb 08, 2022 / 07:00PM GMT
Release Date Price: $7.54 (-1.57%)
Operator

Good day, and welcome to the second annual Winter Wonderland Best Ideas Conference. The next presenting company is Achieve Life Sciences. (Operator Instructions) I'd now like to turn the floor over to today's host, John Bencich, CEO of Achieve Life Sciences. Sir, the floor is yours.

John A. Bencich
Achieve Life Sciences, Inc. - CEO & Director

Great. Thanks for the introduction, and thanks to everyone for joining us today. Before we get going, I'd just like to remind everyone that I may be making forward-looking statements as part of the presentation today. So I would refer everyone to our filings on sec.gov and the risk factors contained therein.

So here in Achieve Life Science, we're focused on the development and ultimately, the commercialization of a drug called cytisinicline as an aid for smoking cessation and treatment for nicotine addiction. And we have a really compelling product on our hands since, one that has a huge amount of historical data supporting the safety and efficacy of the product. There's been extensive research as part of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot